Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference

Reviewed

From Chromatrap® - Porvair Sciences LtdDec 21 2015

Chromatrap^®, a business unit of Porvair Sciences, has announced that it will be the Lead Sponsor at the prestigious “Epigenetics in Drug Discovery” conference to be held in Cambridge, UK from 26^th-27^th January 2016.

Viewed as a new frontier in drug discovery, rapid progress has been made in enhancing understanding of epigenetic mechanisms of both new and existing drugs. With the processes that control epigenomic function providing new opportunities, epigenetics targets are enabling the discovery of novel drugs.

At the conference - Dr Amy Beynon will deliver a presentation highlighting the use of new Chromatrap solid state ChIP technology for assaying methylated and hydroxymethylated DNA marks in addition to Histone modifications and the use of Chromatrap kits for ChIP-sequencing.

Source:

http://www.chromatrap.com/

Posted in: Device / Technology News | Medical Science News | Pharmaceutical News

Tags: CHIP, ChIP-Sequencing, Chromatin Immunoprecipitation (ChIP), DNA, Drug Discovery, Drugs, Epigenetics, Epigenomics, Technology

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Chromatrap® - Porvair Sciences Ltd. (2019, June 24). Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx.
MLA
Chromatrap® - Porvair Sciences Ltd. "Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx>.
Chicago
Chromatrap® - Porvair Sciences Ltd. "Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference". News-Medical. https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx. (accessed November 21, 2024).
Harvard
Chromatrap® - Porvair Sciences Ltd. 2019. Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx.